Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_assertion type Assertion NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_head.
- NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_assertion description "[The pool of ESBL types was overwhelmingly dominated (81.7%) by CTX-M-like beta-lactamases CTX-M-3 (80.6%) and CTX-M-15, with SHV types (17.5%; SHV-2, SHV-5, and SHV-12) and sporadic TEM-like enzymes (0.7%; TEM-19 and TEM-48) being the next most frequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_provenance.
- NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_assertion evidence source_evidence_literature NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_provenance.
- NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_assertion SIO_000772 18458126 NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_provenance.
- NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_assertion wasDerivedFrom befree-20140225 NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_provenance.
- NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_assertion wasGeneratedBy ECO_0000203 NP212374.RABqeEeCpqvSyLFG19MTPbidyQU8iK1RiBG2LdfG3I30w130_provenance.